Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 926 of 1,261

  1. US 8163548

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  2. US 8163707

    4′-allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  3. US 8163709

    TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  4. US 8163720

    Pyrrolidinyl phenyl sulphonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  5. US 8163755

    Hexahydrooxazinopterine compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  6. US 8163737

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  7. US 8163775

    Allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  8. US 8163779

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  9. US 8163881

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  10. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  11. US 8163935

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  12. US 8158580

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  13. US 8158601

    Lipid formulation

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  14. US 8158621

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  15. US 8158677

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  16. US 8158659

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  17. US 8158592

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  18. US 8158581

    IGF-1 fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  19. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  20. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  21. US 8158637

    Quinazolines useful as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  22. US 8158364

    Methods and compositions involving nucleotide repeat disorders

    The Board of Regents of the University of Texas System · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  23. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  24. US 8158773

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.